CyberCyte

CyberCyte, a leading innovator in the realm of Cyber Security, presents a groundbreaking AI-driven platform aimed at revolutionizing risk and threat exposure management. Based in the United Kingdom and founded in 2018, CyberCyte's suite of tools, including their Continuous Threat Exposure Management (X-CTEM), Automated Security Assessment (ASCA), and GRC Management framework, provides comprehensive security risk assessments, ensuring businesses remain vigilant against vulnerabilities and misconfigurations.

The platform's unique approach leverages the power of artificial intelligence to deliver unparalleled visibility and automated responses to emerging threats, thus reducing the complexity of cybersecurity operations and driving down costs. By utilizing an in-depth collection and AI-driven classification of forensic artifacts, CyberCyte not only identifies known risks but also discovers previously unknown vulnerabilities, a critical factor in bolstering cybersecurity infrastructures.

This burgeoning company recently received a significant boost through a Non Equity Assistance investment on 17 September 2024, courtesy of investor Plexal. This infusion is poised to further empower CyberCyte's growth and innovation, enabling them to continue their pioneering work in risk management and cybersecurity solutions.